ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2026
Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany.
Marie Engelhard et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.